{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:27:48Z","timestamp":1792042068181,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long-term exposure to high-risk human papillomavirus (Hr-HPV) is a well-known necessary condition for development of cervical cancer. The aim of this study is to screen for Hr-HPV using vaginal self-sampling, which is a more effective approach to improve women\u2019s adherence and increase screening rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This pilot study included a total of 100 Women living with HIV (WLWHIV), recruited from the Center for Listening, Care, Animation, and Counseling of People Living with HIV in Bamako. Hr-HPV genotyping was performed on Self-collected samples using the Cepheid GeneXpert instrument.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age of WLWHIV was 44 (interquartile range [IQR], 37\u201350) years. Approximately 92% of the study participants preferred self-sampling at the clinic, and 90% opted to receive result notifications via mobile phone contact. The overall prevalence of Hr-HPV among study participants was 42.6%, and the most frequent Hr-HPV sub-types observed were HPV18\/45 (19.1%), HPV31\/35\/33\/52\/58 (13.8%), and HPV39\/68\/56\/66 (12.8%), followed by HPV16 (5.3%), and HPV51\/59 (5.3%). WLWHIV under 35 years of age had a higher frequency of Hr-HPV compared to their older counterparts, with rates of 30% versus 11.1% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03). The duration of antiretroviral treatment showed an inverse association with Hr-HPV negativity, with patients on treatment for 15 (IQR, 10\u201318) years versus 12 (IQR\u2009=\u20097\u201314) years for Hr-HPV positive patients (95% CI [1.2\u20135.8], t\u2009=\u20093.04,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). WLWHIV with baseline CD4 T-Cell counts below 200 exhibited a higher frequency of Hr-HPV compared to those with baseline CD4 T-Cell counts above 200 (17.9% versus 1.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). However, other demographics and clinical factors, such as marital status, age of sexual debut, parity, education, history of abortion, history of preeclampsia, and cesarean delivery, did not influence the distribution of Hr-HPV genotypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate that WLWHIV under the age of 35 years old exhibited the highest prevalence of Hr-HPV infection, with HPV18\/45 being the most prevalent subtype. Additionally, WLWHIV with baseline CD4 T-Cell counts below 200 showed the highest infection rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09412-y","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T07:03:10Z","timestamp":1716361390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ban","family":"Traore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Kassogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brehima","family":"Diakite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fousseyni","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadidiatou","family":"Cisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumar","family":"Kassogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modibo","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aissata","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bourama","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hama","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoumana","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madani","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminata","family":"Maiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidi Boula","family":"Sissoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama Seydou","family":"Sissoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheick Bougadari","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakarou","family":"Kamate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahima","family":"Teguete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekou","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimogo","family":"Dolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demirkan Besim","family":"Gursel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoudou","family":"Maiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"9412_CR1","first-page":"80","volume":"40","author":"P Brianti","year":"2017","unstructured":"Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. 2017;40:80\u20135.","journal-title":"New Microbiol"},{"key":"9412_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12011-022-03226-2","volume":"201","author":"AB Sravani","year":"2023","unstructured":"Sravani AB, Ghate V, Lewis S. Human papillomavirus infection, cervical cancer and the less explored role of trace elements. Biol Trace Elem Res. 2023;201:1026\u201350.","journal-title":"Biol Trace Elem Res"},{"key":"9412_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/cid\/ciab603","volume":"74","author":"JE Tota","year":"2022","unstructured":"Tota JE, Giuliano AR, Goldstone SE, Dubin B, Saah A, Luxembourg A, et al. Anogenital Human Papillomavirus (HPV) infection, seroprevalence, and risk factors for HPV Seropositivity among sexually active men enrolled in a global HPV vaccine trial. Clin Infect Dis. 2022;74:1247\u201356.","journal-title":"Clin Infect Dis"},{"key":"9412_CR4","doi-asserted-by":"crossref","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. Nat Res. 2020;92","DOI":"10.1038\/s41572-020-00224-3"},{"key":"9412_CR5","doi-asserted-by":"publisher","first-page":"1105482","DOI":"10.3389\/fonc.2023.1105482","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li H, Li X, Li Z, You Q, Yi H et al. Associations of human papillomavirus genotypes and cervical vascular abnormality in a cohort of women underwent colposcopy, a retrospective study of 6716 patients. Front Oncol. 2023;13.","journal-title":"Front Oncol"},{"key":"9412_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-030-03502-0_7","volume":"177","author":"CCJ Wang","year":"2019","unstructured":"Wang CCJ, Palefsky JM. HPV-associated anal cancer in the HIV\/AIDS patient. Cancer Treat Res. 2019;177:183\u2013209.","journal-title":"Cancer Treat Res"},{"key":"9412_CR7","doi-asserted-by":"publisher","first-page":"53.e1","DOI":"10.1016\/j.urolonc.2013.08.010","volume":"32","author":"A Flaherty","year":"2014","unstructured":"Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, et al. Implications for human papillomavirus in penile cancer. Urologic Oncology. 2014;32:53.e1-53.e8. Elsevier Inc.","journal-title":"Urol Oncol"},{"key":"9412_CR8","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.3390\/v13122455","volume":"13","author":"CE Condrat","year":"2021","unstructured":"Condrat CE, Filip L, Gherghe M, Cretoiu D, Suciu N. Maternal HPV infection: effects on pregnancy outcome. Viruses. 2021;13.","journal-title":"Viruses"},{"key":"9412_CR9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00404-012-2416-1","volume":"286","author":"M Jamshidi","year":"2012","unstructured":"Jamshidi M, Shekari M, Nejatizadeh AA, Malekzadeh K, Baghershiroodi M, Davudian P, et al. The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts. Arch Gynecol Obstet. 2012;286:1261\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"9412_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical Cancer. Clin Microbiol Rev. 2003;16:1\u201317.","journal-title":"Clin Microbiol Rev"},{"key":"9412_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"J Walboomers","year":"1999","unstructured":"Walboomers J, Jacobs M, Manos M, Bosch F, Kummer J, Shah K, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12\u20139.","journal-title":"J Pathol"},{"key":"9412_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40:602\u20138.","journal-title":"J Obstet Gynaecol"},{"key":"9412_CR13","doi-asserted-by":"publisher","first-page":"814948","DOI":"10.3389\/fcimb.2022.814948","volume":"12","author":"R Zayats","year":"2022","unstructured":"Zayats R, Murooka TT, McKinnon LR. HPV and the risk of HIV acquisition in women. Front Cell Infect Microbiol. 2022;12:814948.","journal-title":"Front Cell Infect Microbiol"},{"key":"9412_CR14","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/ijc.30283","volume":"139","author":"T Fu","year":"2016","unstructured":"Fu T, Carter JJ, Hughes JP, Feng Q, Hawes SE, Schwartz SM, et al. Re-detection vs. new acquisition of high\u2010risk human papillomavirus in mid\u2010adult women. Int J Cancer. 2016;139:2201\u201312.","journal-title":"Int J Cancer"},{"key":"9412_CR15","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890\u2013907.","journal-title":"Lancet"},{"key":"9412_CR16","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/jmv.24284","volume":"87","author":"ML Shew","year":"2015","unstructured":"Shew ML, Ermel AC, Tong Y, Tu W, Qadadri B, Brown DR. Episodic detection of human papillomavirus within a longitudinal cohort of young women. J Med Virol. 2015;87:2122\u20139.","journal-title":"J Med Virol"},{"key":"9412_CR17","doi-asserted-by":"publisher","first-page":"e0221334","DOI":"10.1371\/journal.pone.0221334","volume":"14","author":"S Abel","year":"2019","unstructured":"Abel S, Najioullah F, Volum\u00e9nie J-L, Accrombessi L, Carles G, Catherine D, et al. High prevalence of human papillomavirus infection in HIV-infected women living in French antilles and French Guiana. PLoS ONE. 2019;14:e0221334.","journal-title":"PLoS ONE"},{"key":"9412_CR18","unstructured":"Minist\u00e8re de la Sant\u00e9 du Mali, Cellule de Coordination du Comit\u00e9 Sectoriel de Lutte contre le SIDA, Institut National de Recherche en Sant\u00e9 Publique, Centre de Contr\u00f4le et de Pr\u00e9vention des Maladies (CDC), Agence Am\u00e9ricaine pour le D\u00e9veloppement International (USAID). Enquete integree sur la prevalence et les comportement en matiere d\u2019IST (ISBS) mee au Mali d\u2019Avril a Juin 2009. 2009."},{"key":"9412_CR19","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2016.67.9613","volume":"34","author":"S Dryden-Peterson","year":"2016","unstructured":"Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, et al. HIV infection and survival among Women with Cervical Cancer. J Clin Oncol. 2016;34:3749\u201357.","journal-title":"J Clin Oncol."},{"key":"9412_CR20","doi-asserted-by":"publisher","first-page":"10115","DOI":"10.3390\/ijms221810115","volume":"22","author":"R Marima","year":"2021","unstructured":"Marima R, Hull R, Lolas G, Syrigos KN, Kgoebane-Maseko M, Kaufmann AM, et al. The catastrophic HPV\/HIV dual viral oncogenomics in concert with dysregulated alternative splicing in cervical cancer. Int J Mol Sci. 2021;22:10115.","journal-title":"Int J Mol Sci"},{"key":"9412_CR21","doi-asserted-by":"publisher","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","volume":"8","author":"AJ Kombe Kombe","year":"2020","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda G-A, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related diseases, Molecular Pathogenesis, and vaccine evaluation. Front Public Health. 2020;8:552028.","journal-title":"Front Public Health"},{"key":"9412_CR22","doi-asserted-by":"publisher","first-page":"E116","DOI":"10.1001\/amajethics.2020.116","volume":"22","author":"V Fokom Defo","year":"2020","unstructured":"Fokom Defo V, Fokom Domgue J. Why consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income countries? AMA J Ethics. 2020;22:E116\u2013125.","journal-title":"AMA J Ethics"},{"key":"9412_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12885-017-3723-5","volume":"17","author":"B Allen-Leigh","year":"2017","unstructured":"Allen-Leigh B, Uribe-Z\u00fa\u00f1iga P, Le\u00f3n-Maldonado L, Brown BJ, L\u00f6rincz A, Salmeron J, et al. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study. BMC Cancer. 2017;17:734.","journal-title":"BMC Cancer"},{"key":"9412_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ijgo.12963","volume":"147","author":"RE Kohler","year":"2019","unstructured":"Kohler RE, Elliott T, Monare B, Moshashane N, Ramontshonyana K, Chatterjee P, et al. HPV self-sampling acceptability and preferences among women living with HIV in Botswana. Int J Gynecol Obstet. 2019;147:332\u20138.","journal-title":"Int J Gynecol Obstet"},{"key":"9412_CR25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/1471-2458-14-596","volume":"14","author":"P Bansil","year":"2014","unstructured":"Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:596.","journal-title":"BMC Public Health"},{"key":"9412_CR26","doi-asserted-by":"publisher","first-page":"e40766","DOI":"10.1371\/journal.pone.0040766","volume":"7","author":"AF Rositch","year":"2012","unstructured":"Rositch AF, Gatuguta A, Choi RY, Guthrie BL, Mackelprang RD, Bosire R, et al. Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS ONE. 2012;7:e40766.","journal-title":"PLoS ONE"},{"key":"9412_CR27","doi-asserted-by":"publisher","first-page":"104445","DOI":"10.1016\/j.jcv.2020.104445","volume":"128","author":"A Adedimeji","year":"2020","unstructured":"Adedimeji A, Ajeh R, Dzudie A, Kendowo E, Fuhngwa N, Nsame D, et al. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon. J Clin Virol. 2020;128:104445.","journal-title":"J Clin Virol"},{"key":"9412_CR28","doi-asserted-by":"publisher","first-page":"e0229086","DOI":"10.1371\/journal.pone.0229086","volume":"15","author":"PE Castle","year":"2020","unstructured":"Castle PE, Varallo JE, Bertram MM, Ratshaa B, Kitheka M, Rammipi K. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana. PLoS ONE. 2020;15:e0229086.","journal-title":"PLoS ONE"},{"key":"9412_CR29","doi-asserted-by":"publisher","first-page":"e0137299","DOI":"10.1371\/journal.pone.0137299","volume":"10","author":"PC Adamson","year":"2015","unstructured":"Adamson PC, Huchko MJ, Moss AM, Kinkel HF, Medina-Marino A. Acceptability and accuracy of cervical cancer screening using a self-collected tampon for HPV messenger-RNA testing among HIV-infected women in South Africa. PLoS ONE. 2015;10:e0137299.","journal-title":"PLoS ONE"},{"key":"9412_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12905-016-0360-0","volume":"17","author":"SM Mitchell","year":"2017","unstructured":"Mitchell SM, Pedersen HN, Eng Stime E, Sekikubo M, Moses E, Mwesigwa D, et al. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity. BMC Womens Health. 2017;17:4.","journal-title":"BMC Womens Health"},{"key":"9412_CR31","doi-asserted-by":"publisher","first-page":"105017","DOI":"10.1016\/j.jcv.2021.105017","volume":"145","author":"J Joseph","year":"2021","unstructured":"Joseph J, Mangwendeza P, Maparo T, Mhizha T, Demke O, Murwira S, et al. Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe. J Clin Virol. 2021;145:105017.","journal-title":"J Clin Virol"},{"key":"9412_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12905-023-02279-2","volume":"23","author":"T Megersa","year":"2023","unstructured":"Megersa T, Dango S, Kumsa K, Lemma K, Lencha B. Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia. BMC Womens Health. 2023;23:125.","journal-title":"BMC Womens Health"},{"key":"9412_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40661-017-0041-1","volume":"4","author":"D Obiri-Yeboah","year":"2017","unstructured":"Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, Akakpo K, Aniakwa-Bonsu E, Amoako-Sakyi D, et al. Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana. Gynecol Oncol Res Pract. 2017;4:5.","journal-title":"Gynecol Oncol Res Pract"},{"key":"9412_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ygyno.2018.08.004","volume":"151","author":"LLS Rodrigues","year":"2018","unstructured":"Rodrigues LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, Oliveira NS, Chavez-Juan E, et al. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapaj\u00f3s region, Amazon, Brazil: high acceptability, hrHPV diversity and risk factors. Gynecol Oncol. 2018;151:102\u201310.","journal-title":"Gynecol Oncol"},{"key":"9412_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ijid.2021.06.024","volume":"108","author":"A Jary","year":"2021","unstructured":"Jary A, Teguete I, Sidib\u00e9 Y, Kodio A, Dolo O, Burrel S, et al. Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali. Int J Infect Dis. 2021;108:610\u20136.","journal-title":"Int J Infect Dis"},{"key":"9412_CR36","doi-asserted-by":"publisher","first-page":"e2021039","DOI":"10.4178\/epih.e2021039","volume":"43","author":"JO Okoye","year":"2021","unstructured":"Okoye JO, Ofodile CA, Adeleke OK, Obioma O. Prevalence of high-risk HPV genotypes in sub-saharan Africa according to HIV status: a 20-year systematic review. Epidemiol Health. 2021;43:e2021039.","journal-title":"Epidemiol Health"},{"key":"9412_CR37","doi-asserted-by":"publisher","first-page":"1003461","DOI":"10.3389\/fpubh.2022.1003461","volume":"10","author":"G Di Gennaro","year":"2022","unstructured":"Di Gennaro G, Licata F, Trovato A, Bianco A. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials. Front Public Health. 2022;10.","journal-title":"Front Public Health"},{"key":"9412_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2022.06.012","volume":"166","author":"F Sy","year":"2022","unstructured":"Sy F, Greuel M, Winkler V, Bussmann H, B\u00e4rnighausen T, Deckert A. Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: a systematic review and meta-analysis. Gynecol Oncol. 2022;166:358\u201368.","journal-title":"Gynecol Oncol"},{"key":"9412_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12905-022-01944-2","volume":"22","author":"AL Bogale","year":"2022","unstructured":"Bogale AL, Teklehaymanot T, Ali JH, Kassie GM, Medhin G, Baye AY, et al. Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia. BMC Womens Health. 2022;22:360.","journal-title":"BMC Womens Health"},{"key":"9412_CR40","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.lanepe.2021.100235","volume":"11","author":"F Inturrisi","year":"2021","unstructured":"Inturrisi F, Aitken CA, Melchers WJG, van den Brule AJC, Molijn A, Hinrichs JWJ, et al. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: an observational study. Lancet Reg Health - Europe. 2021;11:100235.","journal-title":"Lancet Reg Health - Europe"},{"key":"9412_CR41","first-page":"37","volume":"11","author":"A Shahid","year":"2020","unstructured":"Shahid A, Abdalla E. The relation of age on HIV-positive women\u2019s cluster of differentiation 4, antiretroviral therapy, papanicolaou test, human papillomavirus test and visual inspection with acetic acid. J Healthc Sci Humanit. 2020;11:37\u201350.","journal-title":"J Healthc Sci Humanit."},{"key":"9412_CR42","unstructured":"Zinzendorf NY, Asher CM, Sandrine ZF, Sandrine AT, Pierre BK, Timot\u00e9e O, et al. International journal of virology and AIDS prevalence and human papillomavirus genotypes distribution among HIV-positive and-negative young women aged 20 to 37-years-old with cervical cancer in Abidjan, C\u00f4te d\u2019Ivoire. 2022."},{"key":"9412_CR43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/1471-2458-14-656","volume":"14","author":"SN Akarolo-Anthony","year":"2014","unstructured":"Akarolo-Anthony SN, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, et al. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health. 2014;14:656.","journal-title":"BMC Public Health"},{"key":"9412_CR44","doi-asserted-by":"publisher","first-page":"e85429","DOI":"10.1371\/journal.pone.0085429","volume":"9","author":"DN Dames","year":"2014","unstructured":"Dames DN, Blackman E, Butler R, Taioli E, Eckstein S, Devarajan K, et al. High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas. PLoS ONE. 2014;9:e85429.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09412-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09412-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09412-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T08:02:19Z","timestamp":1716364939000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09412-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9412"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09412-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the Faculty of Medicine and Odontostomatology\/Faculty of Pharmacy at the University of Sciences, Techniques, and Technologies of Bamako (USTTB) with reference number 2021\/205\/USTTB. Participants provided written informed consent, or fingerprints if they were illiterate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"513"}}